Journey Medical Corp. DERM 深 滬
等待開盤 09-03 09:30:00 美东时间
7.15
-0.060
-0.83%
華盛通- 最 高7.2856
- 今 開7.13
- 成交量 17.65万股
- 最 低 7.05
- 昨 收 7.21
- 總市值 1.67亿
- 52周最高 8.8999
- 市盈率 靜 --
- 換手率 0.76%
- 52周最低 3.535
- 委 比 -73.91%
- 總股本 2329.58万
- 歷史最高 10.20
- 量 比 1.75
- 振 幅 3.27%
- 歷史最低 1.02
- 每 手 1
- 風險率 1.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Journey Medical Corp Enters New Sales Agreement
The latest announcement is out from Journey Medical Corp ( ($DERM) ). On August...
08-29 05:53
HC Wainwright & Co. Initiates Coverage On Journey Medical with Buy Rating, Announces Price Target of $13
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Journey Medical (NASDAQ:DERM) with a Buy rating and announces Price Target of $13.
08-25 19:35
SkinMedica® Unveils Its Newest Hydration Hero
By the makers of BOTOX® Cosmetic (onabotulinumtoxinA), SkinMedica® introduces a next generation amino acid–based cleanser: HA5® Hydra Collagen Hydrating Foaming Cleanser. IRVINE, Calif, Aug....
08-19 20:00
Journey Medical Corporation to Present at the Emerging Growth Conference
Journey Medical Corporation (NASDAQ: DERM) announced that its CEO, Claude Maraoui, will present a corporate overview at the Emerging Growth Conference on August 20, 2025, at 12:35 p.m. ET via a virtual video webcast. For more details or to register, visit EmergingGrowth.com. An archived webcast will be available later. Journey Medical specializes in marketing FDA-approved prescription drugs for dermatological conditions and currently offers eight...
08-18 12:30
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
Examining the Future: Journey Medical's Earnings Outlook
Journey Medical (NASDAQ:DERM) will release its quarterly earnings report on Tue...
08-12 03:03
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
Journey Medical Corporation will ring the Nasdaq closing bell on August 11, 2025, to celebrate its 4-year anniversary as a publicly traded company and the commercial launch of Emrosi™ for rosacea treatment. Claude Maraoui, CEO, highlighted the company's progress and confidence in Emrosi's success to drive profitability and positive EBITDA this year. A live stream of the event will be available.
08-07 12:30
Get Ready, JUVÉDERM® Day is Calling!
Allergan Aesthetics Celebrates Third Annual JUVÉDERM® Day with BOGO Gift Cards and $10,000 Sweepstakes Join Allē Today to Take Advantage of Limited-Time Offers, While Supplies Last IRVINE, C...
08-06 20:00
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
Journey Medical Corporation (Nasdaq: DERM) announced it will release its second quarter 2025 financial results on August 12, 2025, after U.S. markets close. A conference call and audio webcast will follow at 4:30 p.m. ET on the same day. Interested parties can dial 1-866-777-2509 (domestic) or 1-412-317-5413 (international) or register via the provided link. The webcast will be available on the company’s website and remain archived for 30 days. J...
08-05 20:01
B. Riley Securities Maintains Buy on Journey Medical, Raises Price Target to $12
B. Riley Securities analyst Kalpit Patel maintains Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $9 to $12.
07-30 23:51
